Sun Pharmaceutical Industries Ltd (SUNPHARMA) — Announcement | 3 September 2026

3 September 2026 · BSE 🔴 High Importance Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

Sun Pharma announces September 2026 investor meeting schedule

💡 Investor Takeaway

Investors can engage directly with management in upcoming meetings without new price-sensitive disclosures.

Sun Pharmaceutical announced its schedule of upcoming analyst and institutional investor meetings in September 2026, including events with UBS, Jefferies, Kotak, J.P. Morgan, and Anand Rathi, all to be held physically in Mumbai or Delhi. The company emphasized no UPSI will be disclosed during these sessions, and the schedule remains subject to change. These meetings provide investors direct access to management ahead of quarter-end, signaling confidence in near-term performance and transparency in stakeholder engagement.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUNPHARMA ✨ Ask AI About This

About Sun Pharmaceutical Industries Ltd (SUNPHARMA)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹4,41,477.63 CrP/E: 36.5ROE: 14.5%ROCE: 18.7%Div Yield: 0.87%

View full SUNPHARMA stock details →

📡 Get AI alerts when SUNPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUNPHARMA — Free

💡 Ask AI about this filing

"How will Sun Pharma's Q3 results compare to guidance?""What is the valuation multiple relative to peers?""Are there any upcoming product launches or approvals?"

Ask AI Free →

📊 More SUNPHARMA filings

🟡 Corporate Governance — 29 September 2026Sun Pharmaceutical Industries Ltd submitted its ESG Overview for FY 2025-26, detailing governance ch...
🟡 Voting Results — 28 September 2026Sun Pharmaceutical Industries announced the completion of its postal ballot dated 25 August 2026, co...
🔴 Announcement — 28 September 2026Sun Pharma announced a global licensing deal with LIB Therapeutics for lerodalcibep, a PCSK9 inhibit...
🟡 Shareholding Pattern — 26 September 2026Sun Pharmaceutical Industries announced that shareholders approved reclassifying the promoter group ...
Announcement — 25 September 2026Sun Pharmaceutical announces that its trading window will close on 1 October 2026 and remain shut un...

See all SUNPHARMA filings →

🔥 Also filed on 3 September 2026

517554NHC Foods LtdAnnual Report HINDCOMPOSHindustan Composites LtdAnnouncement 534796JUJHAR LOGISTICS LIMITEDAnnual Report 500388Shree Krishna Paper Mills & Industries LtdAnnual Report VSTLVibhor Steel Tubes LtdInsider Trading GAUDIUMIVFGaudium IVF and Women Health LtdAnnual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUNPHARMA files new disclosures

Track SUNPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.